An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 56,788 | 69,635 | 42,262 | 21,574 | 7,284 |
| Operating Income | -56,788 | -69,635 | -42,262 | -21,574 | -7,284 |
| Other Income | 5,467 | 4,903 | 1,306 | 31 | -6,319 |
| Pre-tax Income | -51,321 | -64,732 | -40,956 | -21,543 | -13,603 |
| Net Income Continuous | -51,321 | -64,732 | -40,956 | -21,543 | -13,603 |
| Net Income | $-51,321 | $-64,732 | $-40,956 | $-21,543 | $-13,603 |
| EPS Basic Total Ops | -1.72 | -2.74 | -2.79 | -10.64 | -5.68 |
| EPS Basic Continuous Ops | -1.72 | -2.74 | -2.67 | -8.17 | -5.30 |
| EPS Diluted Total Ops | -1.72 | -2.74 | -2.79 | -10.64 | -5.68 |
| EPS Diluted Continuous Ops | -1.72 | -2.74 | -2.67 | -8.17 | -5.30 |
| EPS Diluted Before Non-Recurring Items | -1.72 | -2.74 | -2.79 | N/A | N/A |
| EBITDA(a) | $-60,067 | $-72,490 | $-42,954 | $-21,521 | $-7,284 |